Woodline Partners’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.7M | Sell |
150,616
-71,427
| -32% | -$9.82M | 0.11% | 277 |
|
|
2025
Q1 | $40M | Buy |
222,043
+941
| +0.4% | +$170K | 0.26% | 117 |
|
|
2024
Q4 | $34.6M | Buy |
221,102
+41,287
| +23% | +$6.47M | 0.23% | 134 |
|
|
2024
Q3 | $32.7M | Sell |
179,815
-112,103
| -38% | -$20.4M | 0.28% | 116 |
|
|
2024
Q2 | $53.6M | Buy |
291,918
+16,463
| +6% | +$3.02M | 0.51% | 50 |
|
|
2024
Q1 | $49M | Sell |
275,455
-206,524
| -43% | -$36.7M | 0.45% | 59 |
|
|
2023
Q4 | $59.8M | Buy |
481,979
+160,035
| +50% | +$19.9M | 0.65% | 37 |
|
|
2023
Q3 | $37.3M | Buy |
321,944
+277,721
| +628% | +$32.2M | 0.44% | 53 |
|
|
2023
Q2 | $5.19M | Buy |
+44,223
| New | +$5.19M | 0.06% | 280 |
|